Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bult

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Blood Cancer Journal|January 4, 2024
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphomaA V de Jonge, J A A Bult, D F E Karssing, et al.
Analytical Biochemistry|May 20, 1995
Degradation kinetics of antagonist [Arg6, D-Trp7,9, MePhe8]-substance P [6-11] in aqueous solutionsJ L Reubsaet, J H Beijnen, A Bult, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 1, 1995
Substitution of didanosine sachets by chewable tablets: a pharmacokinetic study in patients with AIDSD Burger, P Meenhorst, J Mulder, et al.
Brain Research|October 4, 2005
Circadian dynamics of vasopressin in mouse selection lines: translation and release in the SCND R Van der Veen, M R Castillo, E A Van der Zee, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9J D Jonkman-de Vries, H Talsma, R E Henrar, et al.
Anti-Cancer Drugs|October 24, 2002
Stability and compatibility of the investigational polymer-conjugated platinum anticancer agent AP 5280 in infusion systems and its hemolytic potentialM Bouma, B Nuijen, D R Stewart, et al.
Physiology & Behavior|September 27, 2005
Circadian rhythm of core body temperature in two laboratory mouse linesM R Castillo, K J Hochstetler, D M Greene, et al.
Pharmaceutical Research|October 2, 1998
Degradation kinetics of three gonadorelin analogues: developing a method for calculating epimerization parametersM A Hoitink, J H Beijnen, M U Boschma, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatographyO van Tellingen, A L Sonneveldt, J H Beijnen, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 9, 2000
Equivalence testing and equivalence limits of metered-dose inhalers and dry powder inhalers measured by in vitro impactionM Weda, E R Geuns, R C Vermeer, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Blood Cancer Journal|January 4, 2024
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphomaA V de Jonge, J A A Bult, D F E Karssing, et al.
Analytical Biochemistry|May 20, 1995
Degradation kinetics of antagonist [Arg6, D-Trp7,9, MePhe8]-substance P [6-11] in aqueous solutionsJ L Reubsaet, J H Beijnen, A Bult, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 1, 1995
Substitution of didanosine sachets by chewable tablets: a pharmacokinetic study in patients with AIDSD Burger, P Meenhorst, J Mulder, et al.
Brain Research|October 4, 2005
Circadian dynamics of vasopressin in mouse selection lines: translation and release in the SCND R Van der Veen, M R Castillo, E A Van der Zee, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9J D Jonkman-de Vries, H Talsma, R E Henrar, et al.
Anti-Cancer Drugs|October 24, 2002
Stability and compatibility of the investigational polymer-conjugated platinum anticancer agent AP 5280 in infusion systems and its hemolytic potentialM Bouma, B Nuijen, D R Stewart, et al.
Physiology & Behavior|September 27, 2005
Circadian rhythm of core body temperature in two laboratory mouse linesM R Castillo, K J Hochstetler, D M Greene, et al.
Pharmaceutical Research|October 2, 1998
Degradation kinetics of three gonadorelin analogues: developing a method for calculating epimerization parametersM A Hoitink, J H Beijnen, M U Boschma, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatographyO van Tellingen, A L Sonneveldt, J H Beijnen, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 9, 2000
Equivalence testing and equivalence limits of metered-dose inhalers and dry powder inhalers measured by in vitro impactionM Weda, E R Geuns, R C Vermeer, et al.
Pageof 14